NP Life Sciences Health Industry Group Inc.
NPLS
$0.0539
-$0.0962-64.09%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 10.00K | 17.50K | 107.10K | 30.00K | 46.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.00K | 17.50K | 107.10K | 30.00K | 46.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 10.00K | 17.50K | 107.10K | 30.00K | 46.00K |
| SG&A Expenses | 45.90K | 55.00K | 35.70K | 28.80K | 29.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.90K | 55.00K | 35.70K | 28.80K | 29.40K |
| Operating Income | -35.90K | -37.40K | 71.40K | 1.20K | 16.60K |
| Income Before Tax | -36.10K | -37.70K | 71.20K | 1.20K | 16.60K |
| Income Tax Expenses | -20.70K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.40K | -37.70K | 71.20K | 1.20K | 16.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.40K | -37.70K | 71.20K | 1.20K | 16.60K |
| EBIT | -35.90K | -37.40K | 71.40K | 1.20K | 16.60K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 42.96M | 42.96M | 42.96M | 42.96M | 42.96M |
| Average Diluted Shares Outstanding | 42.96M | 42.96M | 42.96M | 42.96M | 42.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
